Enzyme-linked immunosorbent assay: types and applications
H Hayrapetyan, T Tran, E Tellez-Corrales… - ELISA: Methods and …, 2023 - Springer
Enzyme-linked immunosorbent assay (ELISA) is an immunological assay widely used in
basic science research, clinical application studies, and diagnostics. The ELISA technique …
basic science research, clinical application studies, and diagnostics. The ELISA technique …
Recombinant antibodies by phage display for bioanalytical applications
OI Guliy, SS Evstigneeva, LA Dykman - Biosensors and Bioelectronics, 2023 - Elsevier
Antibody phage display, aimed at preparing antibodies to defined antigens, is a useful
replacement for hybridoma technology. The phage system replaces all work stages that …
replacement for hybridoma technology. The phage system replaces all work stages that …
Evolution of phage display libraries for therapeutic antibody discovery
Y Zhang - MAbs, 2023 - Taylor & Francis
Monoclonal antibodies (mAbs) and their derivatives have emerged as one of the most
important classes of biotherapeutics in recent decades. The success of mAb is due to their …
important classes of biotherapeutics in recent decades. The success of mAb is due to their …
Single‐chain fragment variable produced by phage display technology: Construction, selection, mutation, expression, and recent applications in food safety
L Li, S Wu, Y Si, H Li, X Yin… - Comprehensive Reviews in …, 2022 - Wiley Online Library
Immunoassays are reliable, efficient, and accurate methods for the analysis of small‐
molecule harmful substances (such as pesticides, veterinary drugs, and biological toxins) …
molecule harmful substances (such as pesticides, veterinary drugs, and biological toxins) …
Phage display based biosensing: Recent advances and challenges
M Wang, S Pang, H Zhang, Z Yang, A Liu - TrAC Trends in Analytical …, 2024 - Elsevier
Phage display enables to screen probes such as peptide, antibody and nanobody with high
specificity and affinity to the target, providing excellent probes for various analytical or …
specificity and affinity to the target, providing excellent probes for various analytical or …
[HTML][HTML] Progress on phage display technology: tailoring antibodies for cancer immunotherapy
RKA França, IC Studart, MRL Bezerra, LQ Pontes… - Viruses, 2023 - mdpi.com
The search for innovative anti-cancer drugs remains a challenge. Over the past three
decades, antibodies have emerged as an essential asset in successful cancer therapy. The …
decades, antibodies have emerged as an essential asset in successful cancer therapy. The …
[HTML][HTML] Phage display-derived peptides and antibodies for bacterial infectious diseases therapy and diagnosis
H Zhao, D Nie, Y Hu, Z Chen, Z Hou, M Li, X Xue - Molecules, 2023 - mdpi.com
The emergence of antibiotic-resistant-bacteria is a serious public health threat, which
prompts us to speed up the discovery of novel antibacterial agents. Phage display …
prompts us to speed up the discovery of novel antibacterial agents. Phage display …
PhaBOX: a web server for identifying and characterizing phage contigs in metagenomic data
Motivation There is accumulating evidence showing the important roles of bacteriophages
(phages) in regulating the structure and functions of the microbiome. However, lacking an …
(phages) in regulating the structure and functions of the microbiome. However, lacking an …
[HTML][HTML] Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
H Raeisi, M Azimirad, A Nabavi-Rad… - Frontiers in …, 2022 - frontiersin.org
Clostridioides difficile (C. difficile), known as the major cause of antibiotic-associated
diarrhea, is regarded as one of the most common healthcare-associated bacterial infections …
diarrhea, is regarded as one of the most common healthcare-associated bacterial infections …
[HTML][HTML] Can the SARS-CoV-2 omicron variant confer natural immunity against COVID-19?
The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of
abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …